Plasticell gets funding to develop blood substitute from stem cells April 13, 2017 Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, has secured £920,000 from the British government’s Share X Plasticell gets funding to develop blood substitute from stem cells https://pharmaphorum.com/news/plasticell-gets-funding-blood-substitute-stem-cells/
2nd Annual Bioprocessing of Advanced Cellular Therapies Congress March 1, 2017 After the success of the previous edition – Bioprocessing of Advanced Cellular Therapies Congress 2016, MarketsandMarkets is pleased Share X 2nd Annual Bioprocessing of Advanced Cellular Therapies Congress https://pharmaphorum.com/events/2nd-annual-bioprocessing-of-advanced-cellular-therapies-congress/
Cell Culture and Cell Therapy: Bioprocessing Conference March 1, 2017 Cellular therapies hold the potential to revolutionize health care for a variety of diseases. However, the limitations lie Share X Cell Culture and Cell Therapy: Bioprocessing Conference https://pharmaphorum.com/events/cell-culture-cell-therapy-bioprocessing-conference/
Islexa promises revolutionary type 1 diabetes cell therapy May 19, 2016 A UK company has been launched with the aim of curing type 1 diabetes using groundbreaking cell therapy. The new venture Share X Islexa promises revolutionary type 1 diabetes cell therapy https://pharmaphorum.com/news/islexa-promises-revolutionary-type-1-diabetes-cell-therapy/
